Yale Model’s 10.9% Returns: Myth or Blueprint for 2026?
Yale's 10.9% returns: How did they do it? This model, relying on 50%+ alternative assets, offers lessons for investors, but access is key.
Yale's 10.9% returns: How did they do it? This model, relying on 50%+ alternative assets, offers lessons for investors, but access is key.
2024 saw a spike in medical device lawsuits. Learn why and how companies defend against claims, reducing costs by 15% with proactive measures.
Canadian AI firms secured $1.5B in 2025. See how startups like Synapse AI turn research into products with government help.
Canadian tech faces an $8.3 billion VC shortfall in 2025. Understand why startups struggle and what policy changes are needed to compete globally.
Canadian tech conferences fall short. See how events like Improve Festival can deliver real value for 2026 with 5 concrete changes for innovation & investme
Global Energy Group acquired PEM on March 12, 2026. What does this energy media consolidation mean for news diversity and objectivity?
Abbott faces 2026 lawsuits over cardiac, neurological implants. Why patient safety is at risk and what's next for medical device oversight.
Over 1,200 OrthoLife hip implant lawsuits are now consolidated. Learn what this class action means for patient compensation and device accountability.
Why are beauty brands facing a 2026 'proof problem' with claims? See how Aura Cosmetics struggles & what's next for industry credibility.
Staffing firms use AI for 24-month job forecasts. See how their data signals economic shifts 6-9 months early for businesses & policy.